Matches in SemOpenAlex for { <https://semopenalex.org/work/W2333395401> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2333395401 endingPage "iv72" @default.
- W2333395401 startingPage "iv72" @default.
- W2333395401 abstract "ABSTRACT Aim: The present study aimed to discover novel epigenetic biomarkers that could permit identification of CRC patients who are at high-risk of developing tumor recurrence following curative surgery and who are at high-risk of imminent tumor progression following treatments for unresectable cancer. Methods: Given that previous studies have clearly shown that microsatellite stable (MSS) CRC with BRAF mutations have worse outcomes compared to other subgroups, in the initial discovery phase we analyzed a 17-gene methylation biomarker panel consisting of differentially methylated loci in BRAF mutant (V600E) CRCs with microsatellite instability (MSI) and MSS. In the validation phase, we analyzed an independent cohort of 255 stage II/III CRCs that underwent curative resection and 103 stage IV CRCs. Results: We identified that among the 17-genes methylation panel; only MGMT methylation levels were predictive of disease recurrence in CRC. Extensive methylation of the MGMT promoter region was observed in 22% of stage II/III and 16% of stage IV CRCs, and this was significantly associated with relapse -free survival (RFS) (p = 0.03 by Wilcoxon test), but not with overall survival (p = 0.96 by Wilcoxon test) in stage II/III CRC following curative resection. By using Cox proportional hazards regression, for all stage II and III cases, the relative risk ratio for RFS was 2.2 (95%CI; 1.1 to 5.6, p = 0.0359) in MGMT unmethylated vs. methylated CRCs and was 0.62 (0.034 to 3.2, p = 0.627) in MSI vs. MSS CRCs. Of 103 stage IV CRCs, 69(68%) patients were diagnosed as unresectable (unresectable group) cases and 32 (32%) were resectable (resectable group). MGMT methylation was significantly improved overall survival in unresectable group (HR = 0.43 (0.17 to 0.94), p = 0.03, Cox proportional hazards regression). Conclusions: Our data firstly highlight the importance of MGMT methylation status as one of the promising predictive biomarkers that can robustly identify patients who are at risk for disease recurrence in patients following curative surgery in stage III CRC patients and predict the outcomes of stage IV CRC patients with unresectable disease lesions at the time of diagnosis. Disclosure: All authors have declared no conflicts of interest." @default.
- W2333395401 created "2016-06-24" @default.
- W2333395401 creator A5004080101 @default.
- W2333395401 creator A5010475330 @default.
- W2333395401 creator A5010750105 @default.
- W2333395401 creator A5019440060 @default.
- W2333395401 creator A5031516587 @default.
- W2333395401 creator A5035456514 @default.
- W2333395401 creator A5049100460 @default.
- W2333395401 creator A5051559688 @default.
- W2333395401 creator A5055180271 @default.
- W2333395401 creator A5068717107 @default.
- W2333395401 creator A5083726222 @default.
- W2333395401 creator A5086205123 @default.
- W2333395401 date "2014-09-01" @default.
- W2333395401 modified "2023-09-25" @default.
- W2333395401 title "Hypermethylation of O6-Methylguanine-Dna Methyltransferase (Mgmt) Promoter As a Prognostic Biomarker for Stage Ii, III and Iv Colorectal Cancers" @default.
- W2333395401 doi "https://doi.org/10.1093/annonc/mdu326.48" @default.
- W2333395401 hasPublicationYear "2014" @default.
- W2333395401 type Work @default.
- W2333395401 sameAs 2333395401 @default.
- W2333395401 citedByCount "0" @default.
- W2333395401 crossrefType "journal-article" @default.
- W2333395401 hasAuthorship W2333395401A5004080101 @default.
- W2333395401 hasAuthorship W2333395401A5010475330 @default.
- W2333395401 hasAuthorship W2333395401A5010750105 @default.
- W2333395401 hasAuthorship W2333395401A5019440060 @default.
- W2333395401 hasAuthorship W2333395401A5031516587 @default.
- W2333395401 hasAuthorship W2333395401A5035456514 @default.
- W2333395401 hasAuthorship W2333395401A5049100460 @default.
- W2333395401 hasAuthorship W2333395401A5051559688 @default.
- W2333395401 hasAuthorship W2333395401A5055180271 @default.
- W2333395401 hasAuthorship W2333395401A5068717107 @default.
- W2333395401 hasAuthorship W2333395401A5083726222 @default.
- W2333395401 hasAuthorship W2333395401A5086205123 @default.
- W2333395401 hasConcept C104317684 @default.
- W2333395401 hasConcept C121608353 @default.
- W2333395401 hasConcept C126322002 @default.
- W2333395401 hasConcept C143998085 @default.
- W2333395401 hasConcept C146357865 @default.
- W2333395401 hasConcept C150194340 @default.
- W2333395401 hasConcept C151730666 @default.
- W2333395401 hasConcept C190727270 @default.
- W2333395401 hasConcept C2779527866 @default.
- W2333395401 hasConcept C2779979206 @default.
- W2333395401 hasConcept C2781197716 @default.
- W2333395401 hasConcept C33288867 @default.
- W2333395401 hasConcept C502942594 @default.
- W2333395401 hasConcept C526805850 @default.
- W2333395401 hasConcept C54355233 @default.
- W2333395401 hasConcept C552990157 @default.
- W2333395401 hasConcept C71924100 @default.
- W2333395401 hasConcept C86803240 @default.
- W2333395401 hasConcept C91965660 @default.
- W2333395401 hasConceptScore W2333395401C104317684 @default.
- W2333395401 hasConceptScore W2333395401C121608353 @default.
- W2333395401 hasConceptScore W2333395401C126322002 @default.
- W2333395401 hasConceptScore W2333395401C143998085 @default.
- W2333395401 hasConceptScore W2333395401C146357865 @default.
- W2333395401 hasConceptScore W2333395401C150194340 @default.
- W2333395401 hasConceptScore W2333395401C151730666 @default.
- W2333395401 hasConceptScore W2333395401C190727270 @default.
- W2333395401 hasConceptScore W2333395401C2779527866 @default.
- W2333395401 hasConceptScore W2333395401C2779979206 @default.
- W2333395401 hasConceptScore W2333395401C2781197716 @default.
- W2333395401 hasConceptScore W2333395401C33288867 @default.
- W2333395401 hasConceptScore W2333395401C502942594 @default.
- W2333395401 hasConceptScore W2333395401C526805850 @default.
- W2333395401 hasConceptScore W2333395401C54355233 @default.
- W2333395401 hasConceptScore W2333395401C552990157 @default.
- W2333395401 hasConceptScore W2333395401C71924100 @default.
- W2333395401 hasConceptScore W2333395401C86803240 @default.
- W2333395401 hasConceptScore W2333395401C91965660 @default.
- W2333395401 hasLocation W23333954011 @default.
- W2333395401 hasOpenAccess W2333395401 @default.
- W2333395401 hasPrimaryLocation W23333954011 @default.
- W2333395401 hasRelatedWork W1528584527 @default.
- W2333395401 hasRelatedWork W2000742401 @default.
- W2333395401 hasRelatedWork W2048036054 @default.
- W2333395401 hasRelatedWork W2052667621 @default.
- W2333395401 hasRelatedWork W2085764315 @default.
- W2333395401 hasRelatedWork W2113742699 @default.
- W2333395401 hasRelatedWork W2136192296 @default.
- W2333395401 hasRelatedWork W2372572407 @default.
- W2333395401 hasRelatedWork W2980495991 @default.
- W2333395401 hasRelatedWork W4238283142 @default.
- W2333395401 hasVolume "25" @default.
- W2333395401 isParatext "false" @default.
- W2333395401 isRetracted "false" @default.
- W2333395401 magId "2333395401" @default.
- W2333395401 workType "article" @default.